Healthcare · Biotechnology · NASDAQ
| Market cap | $1.77B |
|---|---|
| Trailing P/E | 186.4 |
| FCF yield | -19.3% |
| Revenue growth (YoY) | +15.6% |
| EPS growth (YoY) | -238.5% |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Sarepta Therapeutics, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | May 5, 2025 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Aug 8, 2023 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Jul 6, 2023 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Apr 6, 2023 |
| Daniel Goldman | House | Buy | $15,001 - $50,000 | Apr 3, 2023 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Dec 8, 2020 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Oct 13, 2020 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Jan 6, 2020 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Nov 7, 2019 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Nov 7, 2019 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | May 8, 2019 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Apr 9, 2019 |